公开(公告)号：AU2006235492A1

公开(公告)日：2006-10-19

申请号：AU2006235492

申请日：2006-04-11

Applicant: ABBOTT LAB

Inventor： GANDHI VIRAJKUMAR B ,  ZHU GUIDONG ,  PENNING THOMAS D ,  GIRANDA VINCENT ,  GONG JIANCHUN

IPC: A61K31/4184 ,  A61K31/454 ,  A61K31/55 ,  A61P9/10 ,  C07D401/04 ,  C07D403/04

Abstract: Compounds of Formula (I) (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).

公开(公告)号：DE69809924T2

公开(公告)日：2003-08-21

申请号：DE69809924

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： CURTIN MICHAEL L ,  DAVIDSEN STEVEN K ,  DELLARIA JOSEPH F ,  FLORJANCIC ALAN S ,  GIESLER JAMIE ,  GONG JIANCHUN ,  GUO YAN ,  HEYMAN H ROBIN ,  HOLMS JAMES H ,  MICHAELIDES MICHAEL R ,  STEINMAN DOUGLAS H ,  WADA CAROL K ,  XU LIANHONG

IPC: C07D233/74 ,  A61K31/275 ,  A61K31/351 ,  A61K31/352 ,  A61K31/4035 ,  A61K31/4166 ,  A61K31/4178 ,  A61K31/421 ,  A61K31/428 ,  A61K31/4439 ,  A61K31/4465 ,  A61K31/45 ,  A61K31/454 ,  A61K31/50 ,  A61P1/02 ,  A61P1/04 ,  A61P19/02 ,  A61P19/10 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07C259/06 ,  C07C311/05 ,  C07C311/18 ,  C07C317/28 ,  C07C317/40 ,  C07C323/47 ,  C07C323/62 ,  C07D207/40 ,  C07D207/404 ,  C07D207/416 ,  C07D209/48 ,  C07D211/88 ,  C07D213/68 ,  C07D233/76 ,  C07D233/78 ,  C07D237/14 ,  C07D263/44 ,  C07D275/04 ,  C07D275/06 ,  C07D309/14 ,  C07D311/18 ,  C07D401/06 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07C259/00

Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.

公开(公告)号：HU0002037A2

公开(公告)日：2001-05-28

申请号：HU0002037

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： CURTIN MICHAEL L ,  DAVIDSEN STEVEN K ,  DELLARIA JOSEPH F JR ,  FLORJANCIC ALAN S ,  GIESLER JAMIE ,  GONG JIANCHUN ,  GUO YAN ,  HEYMAN H ROBIN ,  HOLMS JAMES H ,  MICHAELIDES MICHAEL R ,  STEINMAN DOUGLAS H ,  WADA CAROL K ,  XU LIANHONG

IPC: C07D233/74 ,  A61K31/275 ,  A61K31/351 ,  A61K31/352 ,  A61K31/4035 ,  A61K31/4166 ,  A61K31/4178 ,  A61K31/421 ,  A61K31/428 ,  A61K31/4439 ,  A61K31/4465 ,  A61K31/45 ,  A61K31/454 ,  A61K31/50 ,  A61P1/02 ,  A61P1/04 ,  A61P19/02 ,  A61P19/10 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07C259/06 ,  C07C311/05 ,  C07C311/18 ,  C07C317/28 ,  C07C317/40 ,  C07C323/47 ,  C07C323/62 ,  C07D207/40 ,  C07D207/404 ,  C07D207/416 ,  C07D209/48 ,  C07D211/88 ,  C07D213/68 ,  C07D233/76 ,  C07D233/78 ,  C07D237/14 ,  C07D263/44 ,  C07D275/04 ,  C07D275/06 ,  C07D309/14 ,  C07D311/18 ,  C07D401/06 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12

Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.

公开(公告)号：CZ473099A3

公开(公告)日：2000-06-14

申请号：CZ473099

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： CURTIN MICHAEL L ,  DAVIDSEN STEVEN K ,  DELLARIA JOSEPH F JR ,  FLORJANIC ALAN S ,  GIESLER JAMIE ,  GONG JIANCHUN ,  GUO YAN ,  HEYMAN ROBIN H ,  HOLMS JAMES H ,  MICHAELIDES MICHAEL R ,  STEINMAN DOUGLAS H ,  WADA CAROL K ,  XU LIANHONG

IPC: A61K31/16 ,  A61P19/02 ,  A61P35/00 ,  C07C259/00 ,  C07C259/04

公开(公告)号：SK170599A3

公开(公告)日：2000-05-16

申请号：SK170599

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： CURTIN MICHAEL L ,  DAVIDSEN STEVEN K ,  DELLARIA JOSEPH F JR ,  FLORJANCIC ALAN S ,  GIESLER JAMIE ,  GONG JIANCHUN ,  GUO YAN ,  HEYMAN H ROBIN ,  HOLMS JAMES H ,  MICHAELIDES MICHAEL R ,  STEINMAN DOUGLAS H ,  WADA CAROL K ,  XU LIANHONG

IPC: C07D233/74 ,  A61K31/275 ,  A61K31/351 ,  A61K31/352 ,  A61K31/4035 ,  A61K31/4166 ,  A61K31/4178 ,  A61K31/421 ,  A61K31/428 ,  A61K31/4439 ,  A61K31/4465 ,  A61K31/45 ,  A61K31/454 ,  A61K31/50 ,  A61P1/02 ,  A61P1/04 ,  A61P19/02 ,  A61P19/10 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07C259/06 ,  C07C311/05 ,  C07C311/18 ,  C07C317/28 ,  C07C317/40 ,  C07C323/47 ,  C07C323/62 ,  C07D207/40 ,  C07D207/404 ,  C07D207/416 ,  C07D209/48 ,  C07D211/88 ,  C07D213/68 ,  C07D233/76 ,  C07D233/78 ,  C07D237/14 ,  C07D263/44 ,  C07D275/04 ,  C07D275/06 ,  C07D309/14 ,  C07D311/18 ,  C07D401/06 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07C259/00

Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.

公开(公告)号：AU8513998A

公开(公告)日：1999-02-22

申请号：AU8513998

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： CURTIN MICHAEL L ,  DAVIDSEN STEVEN K ,  DELLARIA JOSEPH F ,  FLORJANCIC ALAN S ,  GIESLER JAMIE ,  GONG JIANCHUN ,  GUO YAN ,  HEYMAN H ROBIN ,  HOLMS JAMES H ,  MICHAELIDES MICHAEL R ,  STEINMAN DOUGLAS H ,  WADA CAROL K ,  XU LIANHONG

IPC: C07D233/74 ,  A61K31/275 ,  A61K31/351 ,  A61K31/352 ,  A61K31/4035 ,  A61K31/4166 ,  A61K31/4178 ,  A61K31/421 ,  A61K31/428 ,  A61K31/4439 ,  A61K31/4465 ,  A61K31/45 ,  A61K31/454 ,  A61K31/50 ,  A61P1/02 ,  A61P1/04 ,  A61P19/02 ,  A61P19/10 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07C259/06 ,  C07C311/05 ,  C07C311/18 ,  C07C317/28 ,  C07C317/40 ,  C07C323/47 ,  C07C323/62 ,  C07D207/40 ,  C07D207/404 ,  C07D207/416 ,  C07D209/48 ,  C07D211/88 ,  C07D213/68 ,  C07D233/76 ,  C07D233/78 ,  C07D237/14 ,  C07D263/44 ,  C07D275/04 ,  C07D275/06 ,  C07D309/14 ,  C07D311/18 ,  C07D401/06 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07C259/00

Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.

公开(公告)号：ES2378692T3

公开(公告)日：2012-04-17

申请号：ES06836157

申请日：2006-09-28

Applicant: ABBOTT LAB

Inventor： PENNING THOMAS ,  THOMAS SHEELA ,  ZHU GUI-DONG ,  GANDHI VIRAJKUMAR ,  GONG JIANCHUN ,  GIRANDA VINCENT

IPC: C07D401/10 ,  A61K31/4178 ,  A61K31/454 ,  A61P29/00 ,  A61P31/00 ,  A61P35/00 ,  C07D403/10

Abstract: Un compuesto que tiene la fórmula (I) **Fórmula** o una de sus sales terapéuticamente aceptables, donde R1, R2, y R3 se seleccionan independientemente del grupo que consiste en hidrógeno, alquenilo, alcoxi, alcoxicarbonilo, alquilo, alquinilo, ciano, haloalcoxi, haloalquilo, halógeno, hidroxi, hidroxialquilo, nitro, NRARB, y (NRARB)carbonilo; cada R4 se selecciona independientemente del grupo que consiste en hidrógeno, halógeno, alquilo, y haloalquilo; m es 4; Z es un enlace; A se selecciona del grupo que consiste en **fórmula** cada R5 se selecciona independientemente del grupo que consiste en alquenilo, alcoxi, alcoxialquilo, alcoxicarbonilo, alcoxicarbonilalquilo, alquilo, alquinilo, arilo, arilalquilo, cicloalquilo, cicloalquilalquilo, ciano, haloalcoxi, haloalquilo, halógeno, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, hidroxi, hidroxialquilo, NRCRD, (NRCRD)alquilo, (NRCRD)carbonilo, (NRCRD)carbonilalquilo, y (NRCRD)sulfonilo; R6 se selecciona del grupo que consiste en hidrógeno, alquenilo, alcoxialquilo, alcoxicarbonilo, alcoxicarbonilalquilo, alquilo, alquinilo, arilo, arilalquilo, cicloalquilo, cicloalquilalquilo, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, hidroxialquilo, (NRCRD)alquilo, (NRCRD)carbonilo, (NRCRD)carbonilalquilo, y (NRCRD)sulfonilo; RA, y RB se seleccionan independientemente del grupo que consiste en hidrógeno, alquilo, alquilcarbonilo, y cicloalquilo; RC y RD se seleccionan independientemente del grupo que consiste en hidrógeno, alquilo, y cicloalquilo; y n es 0, 1, 2, o 3.

公开(公告)号：AU2012200398A1

公开(公告)日：2012-02-16

申请号：AU2012200398

申请日：2012-01-23

Applicant: ABBOTT LAB

Inventor： ZHU GUIDONG ,  GONG JIANCHUN ,  GANDHI VIRAJKUMAR B ,  GIRANDA VINCENT ,  PENNING THOMAS D

IPC: C07D401/04 ,  A61K31/4184 ,  A61K31/454 ,  A61K31/55 ,  A61P9/10 ,  C07D403/04

Abstract: 1H-BENZIMIDAZOLE-4-CARBOXAMIDES SUBSTITUTED WITH A QUATERNARY CARBON AT THE 2-POSITION ARE POTENT PARP Abstract 5 Compounds of Formula (I) (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated 1o with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).

公开(公告)号：AT536349T

公开(公告)日：2011-12-15

申请号：AT06836157

申请日：2006-09-28

Applicant: ABBOTT LAB

Inventor： PENNING THOMAS ,  THOMAS SHEELA ,  ZHU GUI-DONG ,  GANDHI VIRAJKUMAR ,  GONG JIANCHUN ,  GIRANDA VINCENT

IPC: C07D401/10 ,  A61K31/4178 ,  A61K31/454 ,  A61P29/00 ,  A61P31/00 ,  A61P35/00 ,  C07D403/10

Abstract: Compounds having formula (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds having formula (I), methods of treatment comprising compounds having formula (I), and methods of inhibiting the PARP enzyme comprising compounds having formula (I).

公开(公告)号：CA2603784C

公开(公告)日：2011-02-08

申请号：CA2603784

申请日：2006-04-11

Applicant: ABBOTT LAB

Inventor： ZHU GUIDONG ,  GONG JIANCHUN ,  GANDHI VIRAJKUMAR B ,  PENNING THOMAS D ,  GIRANDA VINCENT

IPC: C07D403/04 ,  A61K31/4184 ,  A61K31/454 ,  A61K31/55 ,  C07D401/04

Abstract: Compounds of Formula (I) (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).